NeoGenomics Correlations

NEO Stock  USD 12.93  0.44  3.52%   
The current 90-days correlation between NeoGenomics and Exagen Inc is 0.12 (i.e., Average diversification). A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as NeoGenomics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if NeoGenomics moves in either direction, the perfectly negatively correlated security will move in the opposite direction.

NeoGenomics Correlation With Market

Average diversification

The correlation between NeoGenomics and DJI is 0.18 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding NeoGenomics and DJI in the same portfolio, assuming nothing else is changed.
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in NeoGenomics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.
To learn how to invest in NeoGenomics Stock, please use our How to Invest in NeoGenomics guide.

Moving together with NeoGenomics Stock

  0.8NPTH NeuPath HealthPairCorr
  0.64CAH Cardinal HealthPairCorr
  0.65HCA HCA HoldingsPairCorr
  0.85NHC National HealthCarePairCorr
  0.87DR Medical FacilitiesPairCorr
  0.83BIMI Bimi InternationalPairCorr
  0.84WMT Walmart Common Stock Aggressive PushPairCorr
  0.9SAR Saratoga Investment CorpPairCorr

Moving against NeoGenomics Stock

  0.87300015 Aier Eye HospitalPairCorr
  0.79SPI Spire HealthcarePairCorr
  0.74600763 Top Choice MedicalPairCorr
  0.73301267 Huaxia Eye HospitalPairCorr
  0.54OPT Optima Health plcPairCorr
  0.42LH LaboratoryPairCorr
  0.39PHA Premier HealthPairCorr
  0.37UNH UnitedHealth Group CDR Earnings Call TodayPairCorr
  0.31UNH UnitedHealth GroupPairCorr
  0.8ACHC Acadia Healthcare Downward RallyPairCorr
  0.75WELL WELL Health TechnologiesPairCorr
  0.74JD JD Inc AdrPairCorr
  0.61CRVL CorVel CorpPairCorr
  0.55PINC PremierPairCorr
  0.45HNHPF Hon Hai PrecisionPairCorr

Related Correlations Analysis


Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.

High positive correlations

HUMAXGN
SMTISTXS
TKNOHUMA
HUMASTXS
MDXHXGN
SGMTXGN
  

High negative correlations

ACRSXGN
SGMTQTRX
ACRSSTXS
SGMTACRS
QTRXMDXH
ARCTACRS

Risk-Adjusted Indicators

There is a big difference between NeoGenomics Stock performing well and NeoGenomics Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze NeoGenomics' multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
XGN  2.39 (1.25) 0.00 (0.68) 0.00 
 3.11 
 13.49 
MDXH  2.91 (0.35) 0.00 (0.14) 0.00 
 7.53 
 19.70 
STXS  2.65 (0.44) 0.00 (0.16) 0.00 
 4.69 
 18.81 
ACRS  4.02  0.54  0.12  0.62  4.13 
 8.84 
 26.60 
QTRX  3.10  0.22  0.09  0.21  2.85 
 7.89 
 32.49 
SGMT  3.45 (0.60) 0.00 (0.13) 0.00 
 6.39 
 36.94 
SMTI  2.80 (0.40) 0.00 (0.44) 0.00 
 6.96 
 31.68 
ARCT  4.35 (1.33) 0.00 (0.33) 0.00 
 7.42 
 59.77 
HUMA  3.69 (0.72) 0.00 (0.18) 0.00 
 8.16 
 22.74 
TKNO  2.81 (0.38) 0.00 (0.15) 0.00 
 6.29 
 21.07 

NeoGenomics Corporate Management

Nathan MDVice ServicesProfile
George CardozaPres OperationsProfile
Gary PassmanChief OfficerProfile
Alicia OlivoGeneral DevelopmentProfile
Andrew LukowiakChief OfficerProfile
Cynthia DieterChief OfficerProfile